Render Target: STATIC
Render Timestamp: 2024-12-02T11:14:08.275Z
Commit: cd2fae6ca3f811b1ddb1df24ac291ed56d5d501b
XML generation date: 2024-09-20 06:23:16.610
Product last modified at: 2024-08-12T17:45:06.990Z
1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72

Verteporfin #64260

    Product Information

    Product Usage Information

    Verteporfin is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 5 mg of powder in 695 μL of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

    Storage

    Store lyophilized at -20ºC, desiccated. Protect from light. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

    Product Description

    Molecular Weight 718.8 g/mol
    Purity >98%
    Molecular Formula C41H42N4O8
    CAS 129497-78-5
    Solubility Soluble in DMSO at 14 mg/mL.

    Background

    Verteporfin is a benzoporphyrin derivative that is photoactivated by nonthermal red light in the presence of oxygen. It is used clinically as a photosensitizer in photodynamic therapy to treat selected vascular-related diseases. When photoactivated in vasculature, verteporfin generates reactive oxygen species that induce localized damage to endothelial cells, resulting in targeted vessel blockage. Established clinical uses of verteporfin include the treatment of age-related macular degeneration, subfoveal choroidal neovascularization, and pathological myopia (1,2); its anti-angiogenic effects have also led to its consideration as an anti-tumor agent (3). However, the cellular effects of verteporfin exposure extend beyond its photosensitizing activity. It has also been shown to block the interaction between the transcriptional co-activator YAP and TEAD family transcription factors, notably in the absence of photoactivation. This was shown to result in transcriptional repression of YAP target genes that regulate cell proliferation and cell death (4,5), suggesting an additional mechanism by which verteporfin could be utilized as an anti-tumor agent.
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.